IBDEI3BF ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1312,0)
 ;;=TRAUMA/STRESSOR-RELATED DISORDERS^42^110
 ;;^UTILITY(U,$J,358.4,1313,0)
 ;;=SUBSTANCE DISORDER-INHALANT^35^110
 ;;^UTILITY(U,$J,358.4,1314,0)
 ;;=CLINICAL RESEARCH PROGRAM^4^110
 ;;^UTILITY(U,$J,358.4,1315,0)
 ;;=SOMATIC SYMPTOM & RELATED DISORDERS^30^110
 ;;^UTILITY(U,$J,358.4,1316,0)
 ;;=DISRUPTIVE,IMPULSE,CONDUCT D/O^8^110
 ;;^UTILITY(U,$J,358.4,1317,0)
 ;;=ELIMINATION DISORDERS^11^110
 ;;^UTILITY(U,$J,358.4,1318,0)
 ;;=GAMBLING DISORDER^13^110
 ;;^UTILITY(U,$J,358.4,1319,0)
 ;;=OTHER MENTAL DISORDERS^20^110
 ;;^UTILITY(U,$J,358.4,1320,0)
 ;;=NEURODEVELOPMENTAL DISORDERS^18^110
 ;;^UTILITY(U,$J,358.4,1321,0)
 ;;=SUBSTANCE DISORDER-CAFFEINE^32^110
 ;;^UTILITY(U,$J,358.4,1322,0)
 ;;=SUICIDAL IDEATIONS/ATTEMPTS^41^110
 ;;^UTILITY(U,$J,358.4,1323,0)
 ;;=SUBSTANCE DISORDER-UNKNOWN SUBSTANCE^40^110
 ;;^UTILITY(U,$J,358.4,1324,0)
 ;;=SUBSTANCE DISORDER-STIMULANTS^38^110
 ;;^UTILITY(U,$J,358.4,1325,0)
 ;;=UNDERDOSING OF MEDICATION REGIMEN^43^110
 ;;^UTILITY(U,$J,358.4,1326,0)
 ;;=ESTABLISHED PATIENT^1^111
 ;;^UTILITY(U,$J,358.4,1327,0)
 ;;=GROUP PSYCHOTHERAPY/INTERVENTION^2^112
 ;;^UTILITY(U,$J,358.4,1328,0)
 ;;=OTHER^10^112
 ;;^UTILITY(U,$J,358.4,1329,0)
 ;;=TEAM CONFERENCE^9^112
 ;;^UTILITY(U,$J,358.4,1330,0)
 ;;=SUBSTANCE ABUSE^8^112
 ;;^UTILITY(U,$J,358.4,1331,0)
 ;;=CASE MANAGEMENT^1^112
 ;;^UTILITY(U,$J,358.4,1332,0)
 ;;=INJECTION ADMINISTRATION^6^112
 ;;^UTILITY(U,$J,358.4,1333,0)
 ;;=INJECTIONS/MEDICATIONS^7^112
 ;;^UTILITY(U,$J,358.4,1334,0)
 ;;=IN-HOME BEHAVIOR/HEALTH ASSESSMENT^5^112
 ;;^UTILITY(U,$J,358.4,1335,0)
 ;;=IMMUNIZATION ADMINISTRATION ^3^112
 ;;^UTILITY(U,$J,358.4,1336,0)
 ;;=IMMUNIZATIONS^4^112
 ;;^UTILITY(U,$J,358.4,1337,0)
 ;;=ABUSE,NEGLECT, & VIOLENCE^1^113
 ;;^UTILITY(U,$J,358.4,1338,0)
 ;;=ANXIETY DISORDERS^2^113
 ;;^UTILITY(U,$J,358.4,1339,0)
 ;;=BIPOLAR & RELATED DISORDERS^3^113
 ;;^UTILITY(U,$J,358.4,1340,0)
 ;;=NEUROCOGNITIVE DISORDERS^17^113
 ;;^UTILITY(U,$J,358.4,1341,0)
 ;;=DEPRESSIVE DISORDERS^7^113
 ;;^UTILITY(U,$J,358.4,1342,0)
 ;;=DISSOCIATIVE DISORDERS ^9^113
 ;;^UTILITY(U,$J,358.4,1343,0)
 ;;=FEEDING & EATING DISORDERS^12^113
 ;;^UTILITY(U,$J,358.4,1344,0)
 ;;=EDUC/OCCUPATIONAL PROBLEMS^10^113
 ;;^UTILITY(U,$J,358.4,1345,0)
 ;;=GENDER DYSPHORIA^14^113
 ;;^UTILITY(U,$J,358.4,1346,0)
 ;;=HOUSING/ECONOMIC PROBLEMS^15^113
 ;;^UTILITY(U,$J,358.4,1347,0)
 ;;=MEDICATION ADVERSE EFFECTS^16^113
 ;;^UTILITY(U,$J,358.4,1348,0)
 ;;=OBSESSIVE-COMPULSIVE & RELATED DISORDERS^19^113
 ;;^UTILITY(U,$J,358.4,1349,0)
 ;;=PERSONAL HX & CURRENT CIRCUMSTANCES^22^113
 ;;^UTILITY(U,$J,358.4,1350,0)
 ;;=COUNSELING/MEDICAL ADVICE^5^113
 ;;^UTILITY(U,$J,358.4,1351,0)
 ;;=SOCIAL ENVIRONMENT PROBLEMS^29^113
 ;;^UTILITY(U,$J,358.4,1352,0)
 ;;=PARAPHILIC DISORDERS^21^113
 ;;^UTILITY(U,$J,358.4,1353,0)
 ;;=PERSONALITY DISORDERS^23^113
 ;;^UTILITY(U,$J,358.4,1354,0)
 ;;=CRIME/LEGAL SYSTEM PROBLEMS^6^113
 ;;^UTILITY(U,$J,358.4,1355,0)
 ;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^24^113
 ;;^UTILITY(U,$J,358.4,1356,0)
 ;;=RELATIONAL PROBLEMS^25^113
 ;;^UTILITY(U,$J,358.4,1357,0)
 ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^26^113
 ;;^UTILITY(U,$J,358.4,1358,0)
 ;;=SEXUAL DYSFUNCTIONS^27^113
 ;;^UTILITY(U,$J,358.4,1359,0)
 ;;=SLEEP-WAKE DISORDERS^28^113
 ;;^UTILITY(U,$J,358.4,1360,0)
 ;;=SUBSTANCE DISORDER-ALCOHOL^31^113
 ;;^UTILITY(U,$J,358.4,1361,0)
 ;;=SUBSTANCE DISORDER-CANNABIS^33^113
 ;;^UTILITY(U,$J,358.4,1362,0)
 ;;=SUBSTANCE DISORDER-HALLUCINOGEN^34^113
